首页 正文

Aberrant angiogenic signaling in HCC: therapeutic targeting and drug resistance

{{output}}
Liver cancer ranks as the sixth most prevalent malignancy globally, with Hepatocellular Carcinoma (HCC) constituting the predominant subtype, thereby imposing a significant burden on public health and presenting limited therapeutic options. Despite ongoing eff... ...